Not all leaders are good leaders.Perhaps you’ve lost an important executive or you’re establishing a local leadership team. You know that the leader you choose will have a major impact on the organization. So how can you avoid hiring the…
HOME > BUSINESS
BUSINESS
- Plan to Expand AZ-BMS Partnership in Diabetes “on Track”: AZ K.K. Pres. Hudson
November 19, 2012
- Toho HD Confident of Achieving 1% Full-Year Operating Profit Rate in Wholesale Business: Vice-President Kono
November 19, 2012
- Novartis to Revamp Marketing Structure in CNS Field, Shift from SOV
November 19, 2012
- Sawai Aims at Top Positions for New Products in Mediceo Utilizing Mediceo’s ARs: President Sawai
November 19, 2012
- E Keppra Grabs 20% Share of Domestic Anti-Epileptic Drug Market; Sales Growing Rapidly
November 19, 2012
- Medical System Network, Hanshin Dispensing Pharmacy to Set Up New Company for Drug Purchase Next April
November 16, 2012
- Nichi-Iko Aims to Initiate PI Study of Herceptin Biosimilar in FY2013: President Tamura
November 16, 2012
- 3 More Companies Temporarily Discontinue Marketing Generics Due to GMP Non-Compliance at South Korean Supplier
November 16, 2012
- Acquisitions Support Recovery in Leading Domestic Drug Makers’ Overseas Sales Ratio to 37%
November 15, 2012
- Shionogi, ViiV Obtain Favorable Results in 3rd PIII Clinical Trial for Dolutegravir
November 15, 2012
- Healthcare Sales Soar 4.4% with Expansion of Abilify in Japan: Otsuka HD
November 15, 2012
- OrphanPacific to Initiate New Business Model “Contract MAH for Overseas Pharma”
November 15, 2012
- Japan’s 25 Major Drug Makers Log Contrasting Domestic Biz Results on Varying New Product Performances
November 14, 2012
- RaQualia to Slim Down Its Organization Considering Spinning Off Non-Core Development Programs
November 14, 2012
- Towa: 1st Half Sales Up 16%, But Less-than Expected Benefits from Generic Name Prescriptions
November 14, 2012
- Gap between Oncology MRs and Doctors Should Be Closed: Mr Mitsuhashi of Merck Serono
November 13, 2012
- CMIC HD Forms Business Partnership with Japanese Subsidiary of Leading CSO in Europe
November 13, 2012
- Ethical Drug Sales Down 4.9% in September: Crecon Report
November 13, 2012
- Tsumura Postpones Targeted Launch for Kampo Medicine Under Development in US
November 13, 2012
- GeneDesign to Comprehensively Support Development of Nucleic Acid Medicines through New CMC Research Center: Mr Sato
November 13, 2012
ページ
Earlier this month, Health Minister Keizo Takemi called on the top executives of 13 major generic makers to restructure the industry with a product consolidation target of “around five companies per API.” While a variety of restructuring options are conceivable,…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…